Fractyl Health

Endogenex

This company develops an endoscopic system using pulsed electric fields to treat type 2 diabetes by regenerating signalling cells in the small intestine.

Metsera

The company develops injectable and oral medicines for patients with obesity and metabolic diseases.

Ousia Pharma

This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.

Oxford Medical Products

This company develops self-expanding hydrogel capsules to treat obesity in adults by mechanically inducing satiety and suppressing appetite.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

Fable Therapeutics

The company develops protein-engineered biologics using machine learning to treat patients with obesity and metabolic diseases.

Kailera

This biopharmaceutical company develops injectable and oral therapies for the treatment of obesity and related metabolic conditions.

Alveus Therapeutics

This clinical-stage biotechnology company develops next-generation therapies for obesity and metabolic diseases to provide sustained weight loss for patients.